Evolution of the Average Target: Amrize AG

Data source: Amrize AG(AMRZ)

Evolution of the Target Price: Amrize AG

Data source: Amrize AG(AMRZ)

Changes in Analyst Recommendations: Amrize AG

Data source: Amrize AG(AMRZ)
1ecccbb541e1.S4afCn-Qu5jwOFAlikQ9fQ36vRMLqzTiWgm6pV8z9aU.edHsYi3j2aGWThoSxSMNTWyyhVxR33e9CV-C1xlkwOt86MlCKdfqz59_FQ~5d34d27a88c623b2f3bb53c9af1d4c19
09-09 Berenberg Upbeat on Amrize Amid Positive US Construction Demand MT
09-08 Berenberg Upbeat on Holcim Amid Continued Portfolio Evolution; Hold Maintained MT
09-02 JP Morgan Downgrades Amrize to Neutral, Reduces PT MT
09-02 BofA Downgrades Amrize to Underperform From Neutral, Price Target is $40 MT
08-19 Morgan Stanley Cuts Amrize's PT, Affirms Overweight Rating MT
08-18 Berenberg Cuts Amrize Price Target After 'Slightly Disappointing' Q2; Buy Retained MT
08-10 Amrize's Q2 Earnings Miss, EBITDA Guidance Cut Raise Execution Concerns, RBC Capital Markets Says MT
08-10 Oddo BHF Cuts Amrize PT, Keeps Neutral Rating MT
08-10 RBC Downgrades Amrize to Underperform From Sector Perform, Adjusts PT to $48 From $60 MT
07-21 Oppenheimer Adjusts Price Target on Amrize to $65 From $68, Maintains Outperform Rating MT
07-07 Truist Downgrades Amrize to Hold From Buy, Cuts Price Target to $48 From $65 MT
05-14 Morningstar Upgrades Amrize's Rating to Buy MT
05-01 Oppenheimer Adjusts Price Target on Amrize to $68 From $70, Maintains Outperform Rating MT
05-01 RBC Trims Price Target on Amrize to $60 From $61, Keeps Sector Perform Rating MT
02-26 On Field Investment Research Downgrades to Neutral Rating, Raises PT MT
02-23 Deutsche Bank Adjusts Amrize Price Target to $70 From $59, Maintains Buy Rating MT
02-20 Truist Raises Price Target on Amrize to $75 From $60, Keeps Buy Rating MT
02-19 RBC Capital Adjusts Price Target on Amrize to $61 From $60, Maintains Sector Perform Rating MT
02-19 Berenberg Adjusts Price Target on Amrize to $70 From $64, Maintains Buy Rating MT
02-19 Oppenheimer Adjusts Price Target on Amrize to $70 From $64, Maintains Outperform Rating MT
01-08 UBS Adjusts Price Target on Amrize to $57 From $53, Maintains Neutral Rating MT
12-08 Amrize Shares Fall After RBC Downgrade MT
12-08 RBC Downgrades Amrize to Sector Perform From Outperform, Lifts Price Target to $60 From $56 MT
11-26 Vertical Research Starts Amrize Coverage with Hold Rating MT
11-04 Oddo BHF Kicks Off Amrize Coverage with Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+54.5%
+29.26%
+26.62%
+27.62%
+38.56%
+40.88%
+40.82%
+39.6%
Average +37.23%
Weighted average by Cap. +38.43%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
40.65USD
Average target price
57.24USD
Spread / Average Target
+40.82%
High Price Target
71.70USD
Spread / Highest target
+76.40%
Low Price Target
39.44USD
Spread / Lowest Target
-2.97%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BB
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!